-transparent.png){kind=logo}
Rat hippocampal slices preloaded with D-[3H]aspartate, a non metabolizable analogue of L-glutamate, were superfused with artificial CSF. Depolarization was induced by 53.5 mM K+, in the presence of Ca2+ (1.3 mM) or Mg2+ (5 mM) to determine the Ca2+ dependent release. Haloperidol added in the superfusion medium at 100 microM reduced by about 60% the Ca2+ dependent release of D-[3H]aspartate. This drug at 20 microM or 100 microM inhibited the non-activated glutamate dehydrogenase (GDH) but had no effect on GDH activated by ADP (2 mM) or leucine (5 mM). In addition no effect was observed on phosphate activated glutaminase (PAG) in the presence either of 20 mM or 5 mM phosphate. These results indicate that the effect of haloperidol is exerted on presynaptic mechanisms regulating neurotransmitter release.
E Tzavara, and
R Svarna, and
G Palaiologos
March 2001,
Neurochemistry international,
E Tzavara, and
R Svarna, and
G Palaiologos
June 1981,
Nature,
E Tzavara, and
R Svarna, and
G Palaiologos
January 1988,
Synapse (New York, N.Y.),
E Tzavara, and
R Svarna, and
G Palaiologos
March 1996,
Neurochemical research,
E Tzavara, and
R Svarna, and
G Palaiologos
January 1993,
The Journal of pharmacology and experimental therapeutics,
E Tzavara, and
R Svarna, and
G Palaiologos
May 1981,
Neuroscience letters,
E Tzavara, and
R Svarna, and
G Palaiologos
August 1993,
The Journal of pharmacology and experimental therapeutics,
E Tzavara, and
R Svarna, and
G Palaiologos
June 2003,
Neurochemical research,
E Tzavara, and
R Svarna, and
G Palaiologos
May 1991,
European journal of pharmacology,
E Tzavara, and
R Svarna, and
G Palaiologos
October 1990,
The Journal of pharmacology and experimental therapeutics,
